HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

torcetrapib

inhibits cholesteryl ester transfer protein; modest increase in blood pressure led to reevaluation
Also Known As:
CP 529,414; CP 529414; CP-529,414; CP-529414; CP529,414; CP529414
Networked: 87 relevant articles (4 outcomes, 37 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kastelein, John J P: 7 articles (11/2012 - 04/2007)
2. Shear, Charles L: 7 articles (11/2012 - 03/2007)
3. Barter, Philip J: 5 articles (11/2012 - 04/2007)
4. Revkin, James H: 5 articles (11/2007 - 03/2007)
5. Schaefer, Ernst J: 4 articles (06/2013 - 05/2005)
6. Duggan, William T: 4 articles (11/2012 - 03/2007)
7. Tardif, Jean-Claude: 4 articles (08/2011 - 03/2007)
8. Nicholls, Stephen J: 3 articles (01/2022 - 03/2007)
9. Rye, Kerry-Anne: 3 articles (11/2012 - 08/2011)
10. Hermann, Matthias: 3 articles (07/2012 - 01/2009)

Related Diseases

1. Coronary Disease (Coronary Heart Disease)
2. Atherosclerosis
3. Coronary Artery Disease (Coronary Atherosclerosis)
4. Cardiovascular Diseases (Cardiovascular Disease)
5. Hyperlipidemias (Hyperlipidemia)

Related Drugs and Biologics

1. HDL Cholesterol
2. dalcetrapib
3. Atorvastatin (Lipitor)
4. Niacin (Nicotinic Acid)
5. oxidized low density lipoprotein
6. LDL Lipoproteins (beta Lipoproteins)
7. anacetrapib
8. Cholesterol
9. LDL Cholesterol
10. Cholesterol Ester Transfer Proteins

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control